Urinary Biomarkers for Immunotherapy Response in Urothelial Carcinoma: Current Status and Future Outlook
{{output}}
Introduction: Immunotherapy treatments, such as intravesical Bacillus Calmette-Guérin (BCG) for non-muscle invasive bladder cancer (NMIBC) and systemic immune checkpoint inhibitors (ICIs) for all stages are central to the manage... ...
